All About T1D Exchange Research at ADA’s 85th Scientific Sessions
From June 20 to 23, 2025, many of the world’s leading scientists in diabetes research gathered in Chicago, Illinois, for…
What is the Emotional Impact of Screening for T1D?
If you have a family history of type 1 diabetes (T1D) or not, you may be considering screening for the…
Screening My Son for T1D: Early Detection and the Gift of Time
By the time Jaime Lucove was in her late 20s and hoping to start a family, she worried about the…
Part 2: Screening My Son for T1D: Early Detection and the Gift of Time
Living in anticipation: the benefits of delaying T1D It’s been a year since Carter’s Tzield treatment. He is now 15…
Autoantibody Screening for T1D: What Is It and Who Should Get It?
Type 1 diabetes (T1D) is an autoimmune disease in which your immune system mistakenly attacks your beta cells. Eventually, your…
Family Ties and Screening Whys: Decisions in Islet Autoantibody Testing for Type 1 Diabetes
Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes
Phillip, M, et.al Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage…
Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among Centers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Demeterco-Berggren, C, Jacobsen, L, Guttmann-Bauman, I, Ospelt, E, Smego, A, Hannon, T, Aleppo, G, Chouhary, A, Wong, J, Ebekozien, O…
Type 1 Diabetes Screening and Diagnosis
Gomez, P, Sanchez, J KEY POINTS Deciding who and how to screen for T1D has broad clinical and research implications….
Understanding Providers’ Readiness and Attitudes Toward Autoantibody Screening: A Mixed-Methods Study
Ospelt, E, Hardison, H, Rioles, N, Noor, N, Weinstock, R, Cossen, K, Mathias, P, Smego, A, Mathioudakis, N, Ebekozien, O…
